AAT Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin.
Synonyms
Serpin A1; Short peptide from AAT; SPAAT; AAT.
Gene ID
5265
Swiss Prot
P01009
Cellular Locus
Extracellular, Secreted
Host
Rabbit
Cross Reactivity
Human
Target
AAT
Clonality
Recombinant
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human Antithrombin 3
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5265
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-Amino-5-{4-[2- (5-ethyl-pyridin-2-yl) -ethoxy]-benzyl}-thiazol-4-one](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
sc-265383 100 mg
2-Amino-5-{4-[2- (5-ethyl-pyridin-2-yl) -ethoxy]-benzyl}-thiazol-4-one
Sign In for Pricing
View Details